title: Companies use value-based pricing for single-source off-patent drugs.
authors.forename: Cheryl A
authors.initials: CA
authors.lastname: Thompson
mesh_terms: D003365:Costs and Cost Analysis / Q000191:economics* / Q000379:methods; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics* / Q000379:methods; D006801:Humans; D010330:Patents as Topic